(Q40877536)

24 September 2017

1 reference

title

Evaluation of cathepsin D as a prognostic factor in breast cancer (English)

1 reference

24 September 2017

P M Ravdin

1

1 reference

PubMed ID

8435477

24 September 2017

language of work or name

English

0 references

publication date

1 January 1993

1 reference

Breast Cancer Research and Treatment

24 September 2017

1 reference

24 September 2017

24

1 reference

24 September 2017

219-226

1 reference

24 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01833262

24 September 2017

0 references

cites work

Why do so many prognostic factors fail to pan out?

1 reference

12 December 2020

Prognostic value of total cathepsin D in breast tumors. A possible role in selection of chemoresistant patients

1 reference

12 December 2020

Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.

1 reference

12 December 2020

Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings

1 reference

12 December 2020

Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers

1 reference

12 December 2020

Cathepsin D and prognosis in breast cancer

1 reference

12 December 2020

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

1 reference

12 December 2020

Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells

1 reference

12 December 2020

Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein.

1 reference

12 December 2020

Cathepsin D: an independent prognostic factor for metastasis of breast cancer

1 reference

12 December 2020

In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells

1 reference

12 December 2020

The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease

1 reference

12 December 2020

A secreted glycoprotein induced by estrogen in human breast cancer cell lines

1 reference

12 December 2020

Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells

1 reference

12 December 2020

MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D.

1 reference

12 December 2020

Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.

1 reference

12 December 2020

Cathepsin D: a protease involved in breast cancer metastasis

1 reference

12 December 2020

Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells

1 reference

12 December 2020

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

1 reference

12 December 2020

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer

1 reference

12 December 2020

Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays

1 reference

12 December 2020

[Cathepsin D: an independent prognostic factor in cancer of the breast]

1 reference

12 December 2020

Cloning and Sequencing of the 52K Cathepsin D Complementary Deoxyribonucleic Acid of MCF7 Breast Cancer Cells and Mapping on Chromosome 11

1 reference

12 December 2020

Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells

1 reference

12 December 2020

Two-site immunoenzymometric assay for the 52-kDa cathepsin D in cytosols of breast cancer tissues

1 reference

12 December 2020

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01833262

1 reference

PubMed ID

8435477

Dimensions Publication ID

24 September 2017

0 references

1 reference

PubMed ID

8435477